These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8388708)

  • 1. Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D3 receptors in T 47D breast cancer cells.
    Escaleira MT; Sonohara S; Brentani MM
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):257-63. PubMed ID: 8388708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast cancer cells.
    Davoodi F; Brenner RV; Evans SR; Schumaker LM; Shabahang M; Nauta RJ; Buras RR
    J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):147-53. PubMed ID: 7662588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8).
    Liel Y; Kraus S; Levy J; Shany S
    Endocrinology; 1992 May; 130(5):2597-601. PubMed ID: 1315250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
    Wietzke JA; Welsh J
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
    Koga M; Eisman JA; Sutherland RL
    Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-induction of 1,25-dihydroxyvitamin D3 metabolism limits receptor occupancy and target tissue responsiveness.
    Reinhardt TA; Horst RL
    J Biol Chem; 1989 Sep; 264(27):15917-21. PubMed ID: 2550427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
    Reinhardt TA; Horst RL
    Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17 beta-estradiol increases the receptor number and modulates the action of 1,25-dihydroxyvitamin D3 in human osteosarcoma-derived osteoblast-like cells.
    Ishibe M; Nojima T; Ishibashi T; Koda T; Kaneda K; Rosier RN; Puzas JE
    Calcif Tissue Int; 1995 Dec; 57(6):430-5. PubMed ID: 8581875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands.
    Ahonen MH; Zhuang YH; Aine R; Ylikomi T; Tuohimaa P
    Int J Cancer; 2000 Apr; 86(1):40-6. PubMed ID: 10728592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
    Chen J; Wang WQ; Lin SX
    J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.
    Poulin R; Baker D; Labrie F
    Breast Cancer Res Treat; 1988 Oct; 12(2):213-25. PubMed ID: 3242650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of androgens on proliferation and progesterone receptor levels in T47D human breast cancer cells.
    Liberato MH; Sonohara S; Brentani MM
    Tumour Biol; 1993; 14(1):38-45. PubMed ID: 8493449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
    Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3.
    Bellido T; Girasole G; Passeri G; Yu XP; Mocharla H; Jilka RL; Notides A; Manolagas SC
    Endocrinology; 1993 Aug; 133(2):553-62. PubMed ID: 8393768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
    Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
    Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation.
    Koga M; Sutherland RL
    J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):455-60. PubMed ID: 1654997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen down-regulation of androgen receptors in cultured human mammary cancer cells (MCF-7).
    Stover EP; Krishnan AV; Feldman D
    Endocrinology; 1987 Jun; 120(6):2597-603. PubMed ID: 3569146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25(OH)2D3 and dihydrotestosterone interact to regulate proliferation and differentiation of epiphyseal chondrocytes.
    Krohn K; Haffner D; Hügel U; Himmele R; Klaus G; Mehls O; Schaefer F
    Calcif Tissue Int; 2003 Oct; 73(4):400-10. PubMed ID: 12874696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.